{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:26:29Z","timestamp":1784953589342,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.vaccine.2004.07.049","type":"journal-article","created":{"date-parts":[[2004,10,7]],"date-time":"2004-10-07T15:04:01Z","timestamp":1097161441000},"page":"1312-1321","source":"Crossref","is-referenced-by-count":35,"title":["Interactions of proteoliposomes from serogroup B Neisseria meningitidis with bone marrow-derived dendritic cells and macrophages: adjuvant effects and antigen delivery"],"prefix":"10.1016","volume":"23","author":[{"given":"Tamara","family":"Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"M\u00e9nager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Ugrinovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Bracho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Mastroeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.07.049_bib1","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.179.4.1109","article-title":"Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony-stimulating factor plus interleukin 4 and downregulation by tumor necrosis factor","volume":"179","author":"Sallusto","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2004.07.049_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.182.2.389","article-title":"Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products","volume":"182","author":"Sallusto","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2004.07.049_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1084\/jem.185.2.317","article-title":"Maturation stages of mouse dendritic cells in growth factor dependent long-term cultures","volume":"185","author":"Winzler","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2004.07.049_bib4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.immunol.21.120601.141126","article-title":"Toll-Like receptors","volume":"21","author":"Takeda","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2004.07.049_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1600-0609.1993.tb01607.x","article-title":"The biology of macrophages: I. General principles and properties","volume":"51","author":"Seljelid","year":"1993","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.vaccine.2004.07.049_bib6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1574-695X.2000.tb01445.x","article-title":"Salmonella infection of bone marrow-derived macrophages and dendritic cells: influence on antigen presentation and initiating an immune response","volume":"27","author":"Yrlid","year":"2000","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2004.07.049_bib7","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann"},{"key":"10.1016\/j.vaccine.2004.07.049_bib8","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0264-410X(94)00037-N","article-title":"Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease","volume":"13","author":"Boslego","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.07.049_bib9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"Bjune","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.07.049_bib10","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/ije\/24.5.1050","article-title":"Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study","volume":"24","author":"Noronha","year":"1995","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2004.07.049_bib11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1086\/514232","article-title":"Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland","volume":"177","author":"Perkins","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2004.07.049_bib12","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of two serogroup B outer membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2004.07.049_bib13","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/IAI.62.10.4419-4424.1994","article-title":"Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy","volume":"62","author":"Milagres","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.07.049_bib14","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1128\/IAI.69.7.4502-4508.2001","article-title":"Immune response induction and new effector mechanisms possibly involved in protection conferred by the Cuban anti-meningococcal BC vaccine","volume":"69","author":"Perez","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.07.049_bib15","unstructured":"Campa C, Sierra VG, Guti\u00e9rrez MM, Biset G, Garc\u00eda LG, Puentes G, et al. Method of producing Neisseria meningitidis B vaccine, and vaccine produced by method. United States Patent number 5,597,572 (1972)."},{"key":"10.1016\/j.vaccine.2004.07.049_bib16","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/jlb.56.5.616","article-title":"Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation","volume":"56","author":"Li","year":"1994","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2004.07.049_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/(SICI)1521-4141(199901)29:01<180::AID-IMMU180>3.0.CO;2-W","article-title":"Classical MHC class I peptide presentation of a bacterial fusion protein by bone marrow-derived dendritic cells","volume":"29","author":"Svensson","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2004.07.049_bib18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1084\/jem.191.4.613","article-title":"Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells","volume":"191","author":"Yrlid","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2004.07.049_bib19","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","article-title":"Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene","volume":"82","author":"Poltorak","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2004.07.049_bib20","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1128\/IAI.69.11.6912-6922.2001","article-title":"Interaction of Neisseria meningitidis with human dendritic cells","volume":"69","author":"Kolb-M\u00e4urer","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.07.049_bib21","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1128\/IAI.69.7.4351-4357.2001","article-title":"Dendritic cell activation and cytokine production induced by group B Neisseria meningitidis: interleukin-12 production depends on lipopolysaccharide expression in intact bacteria","volume":"69","author":"Dixon GLJ","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.07.049_bib22","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.4049\/jimmunol.129.6.2402","article-title":"Regulation of murine macrophage Ia antigen expression by an immune interferon-like lymphokine: inhibitory effect of endotoxin","volume":"129","author":"Steeg","year":"1982","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2004.07.049_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4049\/jimmunol.139.1.239","article-title":"Suppressed expression of surface Ia on macrophages by lipopolysaccharide: evidence for regulation at the level of accumulation of mRNA","volume":"139","author":"Koerner","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2004.07.049_bib24","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1128\/IAI.65.8.3186-3192.1997","article-title":"Intracellular Salmonella dublin induces substantial secretion of the 40-kilodalton subunit of interleukin-12 (IL12) but minimal secretion of IL12 as a 70-kilodalton protein in murine macrophages","volume":"65","author":"Bost","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.07.049_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/mpat.2001.0448","article-title":"Salmonella typhimurium-induced cytokine production and surface molecule expression by murine macrophages","volume":"31","author":"Svensson","year":"2001","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2004.07.049_bib26","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.1128\/IAI.68.12.6917-6923.2000","article-title":"Gene expression and production of tumor necrosis factor alpha, interleukin-1beta (IL1 beta), IL8, macrophage inflammatory protein 1 alpha (MIP1 alpha), MIP-1beta, and gamma interferon-inducible protein 10 by human neutrophils stimulated with group B meningococcal outer membrane vesicles","volume":"12","author":"Lapinet","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.07.049_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1189\/jlb.70.2.283","article-title":"Contributions of Neisseria meningitidis LPS and non-LPS to proinflammatory cytokine response","volume":"70","author":"Sprong","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2004.07.049_bib28","first-page":"411","article-title":"Neisseria meningitidis can induce pro-inflammatory cytokine production via pathways independent from CD14 and toll-like receptor 4","volume":"13","author":"Sprong","year":"2002","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.vaccine.2004.07.049_bib29","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1128\/IAI.69.8.5031-5036.2001","article-title":"Neisseria meningitidis lipopolysaccharide modulates the specific humoral immune response to neisserial porins but has no effect on porin-induced up-regulation of co-stimulatory ligand B7-2","volume":"69","author":"Bhasin","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.07.049_bib30","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1365-2249.2000.01409.x","article-title":"Gram-negative bacteria induce proinflammatory cytokine production by monocytes in the absence of lipopolysaccharide (LPS)","volume":"122","author":"Uronen","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2004.07.049_bib31","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1002\/1521-4141(2002010)32:10<2800::AID-IMMU2800>3.0.CO;2-5","article-title":"Toll-like receptor 4 is not required for the full maturation of dendritic cells or for the degradation of Gram-negative bacteria","volume":"32","author":"Rescigno","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2004.07.049_bib32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0952-7915(02)00008-0","article-title":"Interaction of bacteria with antigen presenting cells: influences on antigen presentation and antibacterial immunity","volume":"15","author":"Harding","year":"2003","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2004.07.049_bib33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1084\/jem.20021542","article-title":"Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and class II molecules is differentially regulated during dendritic cell maturation","volume":"198","author":"Delamarre","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2004.07.049_bib34","doi-asserted-by":"crossref","first-page":"6502","DOI":"10.4049\/jimmunol.163.12.6502","article-title":"MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants","volume":"163","author":"Simmons","year":"1999","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04006760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04006760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T13:24:41Z","timestamp":1682774681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04006760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0264410X04006760"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.07.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}